Drug
Kpt 8602
Kpt 8602: highest development phase Phase 1/2, developed by Karyopharm Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Karyopharm Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| KPT-8602 NCT02649790 | Phase 1/2 | Relapsed/Refractory Multiple Myeloma (RRMM) |
Latest
No recent events.
Follow Kpt 8602 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.